 Marcelo Perraillon
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicare | 18 | 2025 | 881 | 4.290 |
Why?
| | Early Detection of Cancer | 4 | 2026 | 462 | 1.900 |
Why?
| | Nursing Homes | 5 | 2019 | 172 | 1.290 |
Why?
| | Dementia | 4 | 2022 | 302 | 1.210 |
Why?
| | Fee-for-Service Plans | 5 | 2023 | 97 | 1.170 |
Why?
| | Preventive Health Services | 2 | 2023 | 152 | 1.170 |
Why?
| | Mass Screening | 3 | 2026 | 1332 | 1.100 |
Why?
| | Medicare Part C | 2 | 2025 | 31 | 1.040 |
Why?
| | United States | 37 | 2026 | 15876 | 1.020 |
Why?
| | Lung Neoplasms | 4 | 2025 | 2637 | 1.010 |
Why?
| | Neoplasms | 6 | 2025 | 2870 | 0.960 |
Why?
| | Medicaid | 5 | 2023 | 461 | 0.930 |
Why?
| | SEER Program | 2 | 2024 | 224 | 0.930 |
Why?
| | Depression, Postpartum | 2 | 2025 | 128 | 0.930 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 878 | 0.920 |
Why?
| | Fathers | 1 | 2025 | 51 | 0.860 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 1180 | 0.800 |
Why?
| | Registries | 8 | 2026 | 2382 | 0.790 |
Why?
| | Drug Costs | 2 | 2025 | 115 | 0.780 |
Why?
| | Aged | 29 | 2026 | 25850 | 0.740 |
Why?
| | Colorado | 11 | 2026 | 4562 | 0.740 |
Why?
| | Comparative Effectiveness Research | 1 | 2023 | 169 | 0.710 |
Why?
| | Information Dissemination | 2 | 2022 | 220 | 0.710 |
Why?
| | Antineoplastic Agents | 2 | 2025 | 2192 | 0.680 |
Why?
| | Aged, 80 and over | 18 | 2025 | 8243 | 0.670 |
Why?
| | Medical Record Linkage | 1 | 2021 | 68 | 0.670 |
Why?
| | Mental Status and Dementia Tests | 1 | 2021 | 26 | 0.670 |
Why?
| | Breast Neoplasms | 2 | 2024 | 2447 | 0.650 |
Why?
| | Preventive Medicine | 1 | 2019 | 39 | 0.600 |
Why?
| | Insurance Coverage | 4 | 2023 | 238 | 0.600 |
Why?
| | Prostatic Neoplasms | 1 | 2026 | 974 | 0.570 |
Why?
| | Mothers | 1 | 2025 | 774 | 0.560 |
Why?
| | Research | 1 | 2022 | 428 | 0.560 |
Why?
| | Nootropic Agents | 1 | 2018 | 30 | 0.560 |
Why?
| | Medicare Part D | 1 | 2018 | 23 | 0.560 |
Why?
| | Health Facility Administrators | 1 | 2017 | 6 | 0.530 |
Why?
| | Quality Indicators, Health Care | 2 | 2017 | 335 | 0.530 |
Why?
| | Humans | 51 | 2026 | 144261 | 0.490 |
Why?
| | Pneumonia | 4 | 2013 | 630 | 0.470 |
Why?
| | Homes for the Aged | 1 | 2016 | 32 | 0.470 |
Why?
| | Skilled Nursing Facilities | 4 | 2022 | 151 | 0.460 |
Why?
| | Depression | 1 | 2025 | 1533 | 0.440 |
Why?
| | Female | 34 | 2026 | 77976 | 0.440 |
Why?
| | Healthcare Disparities | 2 | 2018 | 725 | 0.410 |
Why?
| | Male | 29 | 2026 | 72035 | 0.410 |
Why?
| | Clinical Coding | 2 | 2013 | 24 | 0.390 |
Why?
| | Stroke | 4 | 2026 | 1254 | 0.380 |
Why?
| | Internet | 1 | 2016 | 698 | 0.330 |
Why?
| | Hospitalization | 6 | 2025 | 2424 | 0.310 |
Why?
| | Antidepressive Agents | 2 | 2014 | 242 | 0.310 |
Why?
| | Alaska Natives | 2 | 2022 | 149 | 0.290 |
Why?
| | Retrospective Studies | 12 | 2025 | 17009 | 0.280 |
Why?
| | Health Care Costs | 3 | 2022 | 421 | 0.260 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1409 | 0.260 |
Why?
| | Risk Factors | 8 | 2026 | 10699 | 0.240 |
Why?
| | Middle Aged | 13 | 2026 | 35762 | 0.240 |
Why?
| | Socioeconomic Factors | 3 | 2018 | 1312 | 0.230 |
Why?
| | Cohort Studies | 3 | 2025 | 5935 | 0.220 |
Why?
| | Community-Acquired Infections | 3 | 2013 | 174 | 0.220 |
Why?
| | Heart Failure | 4 | 2022 | 2314 | 0.210 |
Why?
| | Long-Term Care | 1 | 2015 | 117 | 0.210 |
Why?
| | Databases, Factual | 4 | 2026 | 1484 | 0.210 |
Why?
| | Patient Discharge | 4 | 2023 | 977 | 0.210 |
Why?
| | Patient Readmission | 3 | 2023 | 756 | 0.210 |
Why?
| | Insurance Claim Review | 2 | 2021 | 82 | 0.200 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2022 | 102 | 0.200 |
Why?
| | Young Adult | 6 | 2026 | 13990 | 0.200 |
Why?
| | Time-to-Treatment | 1 | 2025 | 240 | 0.200 |
Why?
| | Early Medical Intervention | 1 | 2024 | 61 | 0.200 |
Why?
| | Hospice Care | 2 | 2024 | 217 | 0.190 |
Why?
| | Health Surveys | 1 | 2015 | 510 | 0.190 |
Why?
| | Mammography | 1 | 2024 | 165 | 0.190 |
Why?
| | Self-Injurious Behavior | 1 | 2014 | 136 | 0.190 |
Why?
| | Interviews as Topic | 2 | 2017 | 898 | 0.190 |
Why?
| | Diabetes Complications | 2 | 2021 | 220 | 0.190 |
Why?
| | Hormones | 1 | 2023 | 134 | 0.190 |
Why?
| | Causality | 1 | 2023 | 126 | 0.190 |
Why?
| | Adult | 13 | 2026 | 40262 | 0.190 |
Why?
| | Anti-Infective Agents | 2 | 2022 | 242 | 0.180 |
Why?
| | State Government | 1 | 2022 | 46 | 0.180 |
Why?
| | Central Nervous System Infections | 1 | 2022 | 35 | 0.170 |
Why?
| | Nervous System Malformations | 1 | 2022 | 47 | 0.170 |
Why?
| | Nutritional Status | 1 | 2024 | 354 | 0.170 |
Why?
| | Case Management | 1 | 2021 | 66 | 0.170 |
Why?
| | Meningitis | 1 | 2022 | 80 | 0.160 |
Why?
| | Suicide, Attempted | 1 | 2014 | 404 | 0.160 |
Why?
| | Terminal Care | 1 | 2024 | 279 | 0.160 |
Why?
| | Health Expenditures | 1 | 2022 | 194 | 0.160 |
Why?
| | Encephalitis | 1 | 2022 | 139 | 0.160 |
Why?
| | Hospital Mortality | 2 | 2013 | 1027 | 0.150 |
Why?
| | Cost Savings | 1 | 2019 | 86 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2025 | 3592 | 0.150 |
Why?
| | Antipsychotic Agents | 2 | 2008 | 207 | 0.150 |
Why?
| | Hip Fractures | 1 | 2009 | 84 | 0.140 |
Why?
| | Population Surveillance | 1 | 2022 | 483 | 0.140 |
Why?
| | Length of Stay | 2 | 2013 | 1335 | 0.140 |
Why?
| | Health Facility Closure | 1 | 2018 | 8 | 0.140 |
Why?
| | Economics, Hospital | 1 | 2018 | 29 | 0.130 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 688 | 0.130 |
Why?
| | Legislation, Food | 1 | 2017 | 1 | 0.130 |
Why?
| | Trans Fatty Acids | 1 | 2017 | 5 | 0.130 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 919 | 0.130 |
Why?
| | Independent Living | 1 | 2018 | 114 | 0.130 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2926 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2025 | 844 | 0.120 |
Why?
| | Pregnancy | 3 | 2025 | 7180 | 0.120 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 476 | 0.120 |
Why?
| | Indians, North American | 1 | 2022 | 646 | 0.120 |
Why?
| | Health Services Accessibility | 3 | 2022 | 1091 | 0.120 |
Why?
| | Poverty | 1 | 2019 | 523 | 0.120 |
Why?
| | Smoking Cessation | 1 | 2019 | 439 | 0.110 |
Why?
| | Residence Characteristics | 1 | 2018 | 376 | 0.110 |
Why?
| | Awareness | 1 | 2016 | 106 | 0.110 |
Why?
| | Drug Monitoring | 1 | 2008 | 389 | 0.110 |
Why?
| | Motivation | 1 | 2019 | 605 | 0.110 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 95 | 0.110 |
Why?
| | Health Care Surveys | 1 | 2016 | 538 | 0.100 |
Why?
| | Frail Elderly | 1 | 2015 | 133 | 0.100 |
Why?
| | Patient Compliance | 1 | 2007 | 585 | 0.100 |
Why?
| | Physicians | 1 | 2022 | 938 | 0.100 |
Why?
| | Data Collection | 1 | 2016 | 633 | 0.100 |
Why?
| | Patient-Centered Care | 1 | 2018 | 540 | 0.100 |
Why?
| | Adolescent | 4 | 2026 | 22281 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 401 | 0.100 |
Why?
| | Qualitative Research | 2 | 2022 | 1659 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1092 | 0.090 |
Why?
| | Logistic Models | 3 | 2013 | 2104 | 0.090 |
Why?
| | Health Personnel | 1 | 2017 | 742 | 0.080 |
Why?
| | Incidence | 3 | 2014 | 2870 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2015 | 688 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2017 | 1208 | 0.070 |
Why?
| | Sex Factors | 2 | 2026 | 2096 | 0.070 |
Why?
| | Drug Prescriptions | 2 | 2008 | 280 | 0.060 |
Why?
| | Outpatients | 2 | 2011 | 439 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2026 | 2917 | 0.060 |
Why?
| | Comorbidity | 2 | 2011 | 1646 | 0.060 |
Why?
| | Aging | 1 | 2016 | 1964 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5813 | 0.050 |
Why?
| | Death | 1 | 2023 | 130 | 0.050 |
Why?
| | Subacute Care | 1 | 2023 | 82 | 0.050 |
Why?
| | United States Indian Health Service | 1 | 2022 | 45 | 0.040 |
Why?
| | Morbidity | 1 | 2022 | 323 | 0.040 |
Why?
| | Pharmaceutical Services | 1 | 2021 | 78 | 0.040 |
Why?
| | Schools | 1 | 2024 | 452 | 0.040 |
Why?
| | Age Distribution | 1 | 2011 | 397 | 0.040 |
Why?
| | Sex Distribution | 1 | 2011 | 380 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2011 | 130 | 0.040 |
Why?
| | Observation | 1 | 2009 | 54 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2009 | 36 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2020 | 137 | 0.040 |
Why?
| | Respiratory Insufficiency | 1 | 2013 | 326 | 0.040 |
Why?
| | Diphosphonates | 1 | 2009 | 68 | 0.040 |
Why?
| | Child | 3 | 2024 | 22537 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2011 | 177 | 0.040 |
Why?
| | Bone Density Conservation Agents | 1 | 2009 | 81 | 0.040 |
Why?
| | Drug Utilization | 1 | 2009 | 166 | 0.040 |
Why?
| | Estrogen Replacement Therapy | 1 | 2009 | 143 | 0.040 |
Why?
| | Documentation | 1 | 2020 | 197 | 0.040 |
Why?
| | Infant | 2 | 2024 | 10022 | 0.040 |
Why?
| | Mortality | 1 | 2011 | 371 | 0.030 |
Why?
| | Odds Ratio | 1 | 2011 | 1072 | 0.030 |
Why?
| | Disease Management | 1 | 2022 | 643 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2021 | 11643 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1322 | 0.030 |
Why?
| | New York | 1 | 2017 | 124 | 0.030 |
Why?
| | Models, Biological | 1 | 2014 | 1820 | 0.030 |
Why?
| | Sepsis | 1 | 2013 | 640 | 0.030 |
Why?
| | Inpatients | 1 | 2011 | 542 | 0.030 |
Why?
| | Body Weight | 1 | 2020 | 976 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2021 | 777 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2008 | 964 | 0.030 |
Why?
| | Risk | 1 | 2008 | 909 | 0.030 |
Why?
| | Age Factors | 1 | 2013 | 3313 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 946 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 998 | 0.030 |
Why?
| | Consumer Behavior | 1 | 2015 | 69 | 0.030 |
Why?
| | Communication | 1 | 2021 | 961 | 0.030 |
Why?
| | Time Factors | 1 | 2014 | 7155 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6021 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1906 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6424 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 7970 | 0.020 |
Why?
|
|
Perraillon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|